Is Trump Media similar to Kodak entering the pharmaceutical business, or like a SPAC merging with an EV start-up?

Pot stocks fell for the second day Friday, but traders may be underestimating cost savings from Trump’s move to reclassify ...

Sanctuary Wealth’s chief investment strategist says 2026 will be a “reset year” because of high valuations and challenging ...

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.

The Trump administration has talked tough about cutting drug prices, but the impacts of the deals with drug companies ...

Younger advisors are choosing gifts that connect with clients’ values and are sometimes opting for experiences over things.

Lamb Weston reported 44 cents in earnings per share, compared with the 25-cents loss a year earlier thanks to restructuring ...

Cannabis stocks remain under pressure after President Donald Trump signed an executive order Thursday directing the Department of Justice to reschedule marijuana as a lower-class drug.

It will take serious convincing for investors to return to Venezuela, Ben Cahill writes in a guest commentary.

Costco Renewal-Rate Concerns Are Overblown, Says Analyst. Plus, Zillow, Micron Tech, and More Stocks.

Readers weigh in on Kevin Hassett, the Fed’s purchase of T-bills, a vote against Comcast and MSGS, and the case for Cal-Maine Foods ...

Many individuals and companies are known to have had a relationship with Jeffrey Epstein. Will the expected Friday release of ...